This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Takemoto SK et al. (2004) National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant 4: 1033–1041
Jordan SC et al. (2006) Intravenous gammaglobulin (IVIG): a novel approach to improve transplant rates and outcomes in highly HLA-sensitized patients. Am J Transplant 6: 459–466
Montgomery RA et al. (2000) Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 70: 887–895
Jordan SC et al. (2004) Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial. J Am Soc Nephrol 15: 3256–3262
Zachary AA et al. (2003) Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients. Transplantation 76: 1519–1525
Acknowledgements
The synopsis was written by Rachael Williams, Assistant Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Bunnapradist, S. Does plasmapheresis desensitize kidney transplant recipients more effectively than high-dose immunoglobulin?. Nat Rev Nephrol 2, 484–485 (2006). https://doi.org/10.1038/ncpneph0266
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpneph0266